covid-19

Full title: 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records Background Neurological and psychiatric sequelae of COVID-19 have been reported, but more data are needed to adequately assess the effects of...

Expert Forum on secondary COVID-19 impacts Virtual Expert Forum with internal and external experts addressed the diagnosis, management, and prognosis of the most common lasting symptoms of COVID-19 14:10 Long-haulers and chronic fatigue Trends in fatigue due to Secondary COVID Syndrome...

https://onlinelibrary.wiley.com/doi/10.1111/eci.13554 Abstract Background Estimates of community spread and infection fatality rate (IFR) of COVID‐19 have varied across studies. Efforts to synthesize the evidence reach seemingly discrepant conclusions. Methods Systematic evaluations of...

(Paragraphed for clarity) Although post-acute cognitive dysfunction and neuroimaging abnormalities have been reported after hospital discharge in patients recovered from COVID-19, little is known about persistent, long-term alterations in people without hospitalization. We conducted a...

Objective Most SARS‐CoV‐2‐infected individuals never require hospitalization. However, some develop prolonged symptoms. We sought to characterize the spectrum of neurologic manifestations in non‐hospitalized Covid‐19 “long haulers”. Methods This is a prospective study of the first 100...

OBJECTIVE: To evaluate the timing, duration, and health impacts of PASC reported by a large group of primarily non-hospitalized COVID-19 survivors. DESIGN, SETTING, AND PARTICIPANTS: A survey of 5,163 COVID-19 survivors reporting symptoms for more than 21 days following SARS-CoV-2 infection...

Article by Lindsey Tanner - Survivors Struggle as Scientists Race to Solve COVID Mystery https://www.medscape.com/viewarticle/947450 (you may need to register to read article) Nothing much new here. Mentions the $1 billion allocated for NIH research, lists some working theories why symptoms...

Background COVID-19 is a syndrome caused by the recently emerged SARS-CoV-2. We collected clinical and epidemiologic data in an almost complete cohort of SARS-CoV-2 positive individuals from Regensburg, Germany, from March 2020 to May 2020. Methods Analysis of a retrospectively documented...

The pandemic of the coronavirus disease 2019 (COVID-19) has provoked a second pandemic, the “long-haulers”, i.e., individuals presenting with post-COVID symptoms. We propose that to determine the presence of post-COVID symptoms, symptoms should appear after the diagnosis of SARS-CoV-2 infection...

https://www.ninds.nih.gov/Current-Research/Coronavirus-and-NINDS/nervous-system

Open access, https://www.metabolismjournal.com/article/S0026-0495(21)00039-1/fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889402/ Abstract In late 2019, a novel coronavirus SARS-CoV-2 (COVID-19) spread unchecked across the world's population. With tens of millions infected, the long-term consequences of COVID-19 infection will be a major health care focus for years...

https://www.medrxiv.org/content/10.1101/2020.12.10.20247205v5

Full title: Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition? Open access, https://www.sciencedirect.com/science/article/pii/S1359644621000751

This thread has been split from the Covid-19 Vaccines and Vaccination thread. I had my Covid-19 jab yesterday (Oxford/AstraZeneca), and thought people might be interested in my reaction to it. However, this should be taken in context: 1. I don't have ME. 2. The day before, I was under a...

https://www.mdpi.com/2073-4409/10/2/386 Abstract As the SARS-CoV-2 pandemic continues, reports have demonstrated neurologic sequelae following COVID-19 recovery. Mechanisms to explain long-term neurological sequelae are unknown and need to be identified. Plasma from 24 individuals recovering...

https://www.biorxiv.org/content/10.1101/2021.02.12.429482v1.full

Open access, https://www.mdpi.com/1660-4601/18/4/1453

The Team of Doctors and Biohackers Who Seem to Be Successfully Treating “Long Covid” There’s actually quite a number of research papers on this.

From an email from Solve. Last month, Solve M.E. identified yet another COVID-19 relief package funding opportunity for ME/CFS and worked with our friends on Capitol Hill to outline additional federal post-viral research and medical education investments. Ten other ME/CFS organizations joined...